Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors.
Leuk Res
; 81: 82-87, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-31055247
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Drug Resistance, Neoplasm
/
Isocitrate Dehydrogenase
/
Mutation
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leuk Res
Year:
2019
Type:
Article
Affiliation country:
France